Analytical Data
-
Gene name
CPA5
- Application
-
Alternative Names
CPA5；Carboxypeptidase A5
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WXQ8
-
Expression Region
127-436aa
-
AA Sequence
LERS TNSFSYSSYH TLEEIYSWID NFVMEHSDIV SKIQIGNSFE NQSILVLKFS TGGSRHPAIW IDTGIHSREW ITHATGIWTA NKIVSDYGKD RVLTDILNAM DIFIELVTNP DGFAFTHSMN RLWRKNKSIR PGIFCIGVDL NRNWKSGFGG NGSNSNPCSE TYHGPSPQSE PEVAAIVNFI TAHGNFKALI SIHSYSQMLM YPYGRLLEPV SNQRELYDLA KDAVEALYKV HGIEYIFGSI STTLYVASGI TVDWAYDSGI KYAFSFELRD TGQYGFLLPA TQIIPTAQET WMALRTIMEH TLNHPY
-
Molecular Weight
49 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The CPA5 protein, a member of the calcium-dependent phospholipid-binding protein family, has gained attention in recent years due to its potential roles in various biological processes and implications in diseases. Research has shown that CPA5 is involved in cellular signaling pathways, particularly in regulating inflammation and apoptosis, which are critical in immune responses and cancer progression. Its expression levels have been associated with several pathological conditions, including autoimmune diseases and malignancies, making it a candidate for therapeutic targeting and biomarker development. Furthermore, structural studies of CPA5 have revealed insights into its binding mechanisms and interactions with lipid membranes, which are essential for understanding its functional role in health and disease. The ongoing exploration of CPA5's structure, function, and biological significance aims to elucidate its contributions to pathophysiological processes, potentially leading to novel strategies for disease intervention and treatment.
